Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Beijing Wantai Biological Phar (603392 CH)
Watchlist
29
Analysis
Health Care
•
China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. manufactures medical products. The Company produces enzyme linked immunodiagnostic reagents, colloidal gold rapid diagnostic reagents, vaccines, biochemical reagents, and other products. Beijing Wantai Biological Pharmacy Enterprise also produces diagnostic equipment.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Chongqing Zhifei Biological Products
•
27 Oct 2022 08:54
Zhifei Biological Products (300122.CH) - More Downside Ahead, with Untenable Logic in HPV Vaccine
Zhifei’s HPV vaccine will face real risk as competing products launch from 2024. The real potential of China HPV vaccine market is much lower than...
Xinyao (Criss) Wang
Follow
165 Views
Share
bullish
•
Thematic (Sector/Industry)
•
23 Oct 2022 09:24
China Healthcare Weekly (Oct.21) - Electrophysiology VBP; Orthodontics VBP New Progress; HPV Vaccine
Unlike others' optimism,we see potential concerns in electrophysiology VBP; Orthodontics VBP is beyond expectation since invisible braces are...
Xinyao (Criss) Wang
Follow
288 Views
Share
bearish
•
Thematic (Sector/Industry)
•
07 Jul 2022 08:51
Monkeypox and Its Impact on China
Monkeypox's rapid spread raises concerns. China bears the pressure of imported cases, but it’s difficult to replicate the growth story of COVID-19...
Xinyao (Criss) Wang
Follow
231 Views
Share
bearish
•
Thematic (Sector/Industry)
•
26 Apr 2022 08:12
China A-Shares: Biotechnology Exit
Allocations in Biotechnology stocks have taken a severe drop among active China A-Share investors. From a high of 4% in July of 2020, average fund...
Steven Holden
Follow
215 Views
Share
bearish
•
Chongqing Zhifei Biological Products
•
18 Apr 2022 08:55
Chongqing Zhifei Biological Products (300122.CH) - WHO's One-Dose HPV Vaccine Regimen & The Outlook
WHO’s recommendation on HPV vaccines is not the biggest risk of Zhifei and won't affect short-term performance, but the valuation logic...
Xinyao (Criss) Wang
Follow
395 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x